NAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed
PR Newswire (AI)en
PR Newswire (AI)
AI Global WireNAVER D2SF, NAVER's inhouse corporate venture arm, has invested in ImpriMed, a Silicon Valley-based precision medicine company, ...
This is a short summary published by AI Global Wire. The full article is owned and hosted by PR Newswire (AI) — open it there to read it in full.
Read the full story at PR Newswire (AI)Related AI news
- Mistral and other European AI startups accuse US rivals of using safety concerns to entrench their dominance, rejecting Anthropic's calls to pace the frontier (Reuters)Techmeme · September 18, 2026
- Google’s new ‘CC’ is an AI agent that helps families run their householdsTechCrunch AI · September 18, 2026
- Japan's Sojitz plans chip materials transport hub for Tata fab in IndiaNikkei Asia · September 18, 2026
- US government website used Chinese model the FBI called "malicious"Ars Technica AI · September 18, 2026
- What to expect during CoreWeave’s ‘Fully Connected’ event: Join theCUBE Sept. 30-Oct. 1SiliconANGLE · September 18, 2026
- Security researchers used Anthropic's Claude to hack OpenAI's internal systems in under 72 hoursThe Decoder · September 18, 2026